Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients

Back

ESC Premium Access

Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients

Session: Inflammatory and Infectious Disorders and Heart Disease

Topic: HIV and Cardiovascular Disease

Speaker: Doctor M. Frias (Geneva, CH)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Miguel Frias

University hospitals of Geneva, Geneva (Switzerland)

0 follower

5 more presentations in this session

Genetically rheumatoid arthrits and risk of comorbidities: a Mendelian randomization study

Speaker: Ms A. Fokina (Vienna, AT)

Access

Abstract

Slides

Predictors of subclinical right ventricular dysfunction and pulmonary hypertension in asymptomatic patients with pulmonary sarcoidosis

Speaker: Doctor I. Evsikova (Saint Petersburg, RU)

Access

Abstract

Slides

Survey of cardiovascular disease and risk factor management in patients with rheumatoid arthritis across 5 world regions: Results from the SURF-RA

Speaker: Assistant Professor A. Semb (Oslo, NO)

Access

Abstract

Slides

Can quantitative 18F-FDG PET/CT and serum cytokine analysis differentiate ARVC from cardiac sarcoidosis?

Speaker: Doctor H. Abbas (Aberdeen, GB)

Access

Abstract

Slides

The systemic immune-inflammation index is associated with early postoperative morbidity and mortality following cardiac surgery

Speaker: Doctor R. Rosalia (Skopje, MK)

Access

Abstract

Slides

Access the full session

Inflammatory and Infectious Disorders and Heart Disease

Speakers: Doctor M. Frias, Ms A. Fokina, Doctor I. Evsikova, Assistant Professor A. Semb, Doctor H. Abbas...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources